Overview

Prevention of Venous Thromboembolism in Patients With Acute Primary Intracerebral Hemorrhage

Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
- To evaluate the efficacy of using IPC during the acute phase of ICH in the prevention of VTE. - To assess the safety and efficacy of additional therapy with enoxaparin. - To compare the efficacy and safety of the European and American guideline recommendations. - To provide an efficient and safe thromboprophylaxis for several weeks until the patient is able to walk.
Phase:
Phase 4
Details
Lead Sponsor:
University of Oulu
Collaborators:
Helsinki University
University of Helsinki
Treatments:
Enoxaparin
Enoxaparin sodium